<p>Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis</p>-Reference-Cited by-同舟云学术

Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis

Published:2020-03 Issue: Volume:Volume 15 Page:1731-1743
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Chou Pi-Ling,Huang Ya-Ping^ORCID,Cheng Meng-Hsuan^ORCID,Rau Kun-Ming^ORCID,Fang Yi-Ping

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Reference53 articles.

1. Managing taxane toxicities

2. Paclitaxel (Taxol)

3. Drug Delivery Systems: Entering the Mainstream

4. International Journal of Nanomedicine

5. Crystal and molecular structure of paclitaxel (taxol).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential;Advanced Healthcare Materials;2024-09-14

2. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments;International Journal of Pharmaceutics;2024-07

3. Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

4. PEGylated mesoporous silica core–shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells;International Journal of Pharmaceutics;2024-04

5. Anticancer therapy-induced adverse drug reactions in children and preventive and control measures;Frontiers in Pharmacology;2024-02-15